Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
| ▸ | PDE4A | P27815 | 1/20 | 0.57 |
| ▸ | SNCA | P37840 | 1/20 | 0.57 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | VKORC1 | Q9BQB6 | 1/20 | 0.37 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.37 |
| ▸ | CDC25B | P30305 | 1/20 | 0.37 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28023376 | 1.00 | PTGS1 (0.57) | PTGS1PDE4ASNCAPDE3APTPN1 | |
| SCHEMBL29357300 | 1.00 | PTGS1 (0.57) | PTGS1PDE4ASNCAPDE3APTPN1 | |
| SCHEMBL29474878 | 1.00 | PTGS1 (0.57) | PTGS1PDE4ASNCAPDE3APTPN1 | |
| SCHEMBL25976874 | 0.95 | PTGS1 (0.49) | PTGS1PDE4ASNCAPDE3APTPN1 | |
| Pyrophosphoric Acid SCHEMBL9711032 | 0.91 | PTGS1 (0.51) | PTGS1PDE4ASNCAPDE3APTPN1 | |
| SCHEMBL19327403 | 0.88 | PTGS1 (0.50) | PTGS1PDE4ASNCAPDE3APTPN1 | |
| SCHEMBL22172548 | 0.86 | PTGS1 (0.58) | PTGS1PDE4ASNCAPDE3APTPN1 | |
| SCHEMBL22172508 | 0.86 | PTGS1 (0.58) | PTGS1PDE4ASNCAPDE3APTPN1 | |
| SCHEMBL13597513 | 0.86 | PTPN1 (0.55) | PTGS1PDE4ASNCAPDE3APTPN1 | |
| SCHEMBL2138789 | 0.86 | PTPN1 (0.55) | PTGS1PDE4ASNCAPDE3APTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4232004-A1 | FRACTAL FORMULATIONS | Nanogyre Sprl (BE) | 2023-08-30 | — | — | EP | claimed |
| WO-2021078412-A1 | FRACTAL FORMULATIONS | MESSADEK JALLAL (BE) | 2021-04-29 | — | — | WO | claimed |
| US-20190000862-A1 | METHODS AND SYSTEMS FOR THE DELIVERY OF A THERAPEUTIC AGENT | HANANJA EHF (IS) | 2019-01-03 | — | — | US | claimed |
| US-10144692-B2 | Method of making vitamin K1 | Sunny Pharmtech Inc. (TW) | 2018-12-04 | — | — | US | claimed |
| US-9801855-B2 | Nanocrystalline solid dispersion compositions and process of preparation thereof | NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER) (IN) | 2017-10-31 | — | — | US | claimed |
| US-20170260117-A1 | Method of Making Vitamin K1 | Sunny Pharmtech Inc. (TW) | 2017-09-14 | — | — | US | claimed |
| EP-3207020-A1 | METHOD OF MAKING VITAMIN K1 | Sunny Pharmtech Inc., (TW) | 2017-08-23 | — | — | EP | claimed |
| EP-2712613-B1 | Vitamin K1 and uses thereof | PHARMADAB D O O (SI) | 2017-02-08 | — | — | EP | claimed |
| US-20160220505-A1 | COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE COMPOUNDS AND METHOD FOR THEIR PREPARATION | SOLUBEST LTD. (IL) | 2016-08-04 | — | — | US | claimed |
| WO-2016060670-A1 | METHOD OF MAKING VITAMIN K1 | Sunny Pharmtech Inc. (TW) | 2016-04-21 | — | — | WO | claimed |
| US-20150132385-A1 | NANOCRYSTALLINE SOLID DISPERSION COMPOSITIONS AND PROCESS OF PREPARATION THEREOF | NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER) (IN) | 2015-05-14 | — | — | US | claimed |
| EP-2822539-A2 | NANOCRYSTALLINE SOLID DISPERSION COMPOSITIONS AND PROCESS OF PREPARATION THEREOF | National Institute Of Pharmaceutical Education And Research (NIPER) (IN) | 2015-01-14 | — | — | EP | claimed |
| WO-2013132457-A2 | NANOCRYSTALLINE SOLID DISPERSION COMPOSITIONS AND PROCESS OF PREPARATION THEREOF | NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER) (IN) | 2013-09-12 | — | — | WO | claimed |
| EP-2200588-A1 | COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE COMPOUNDS AND METHOD FOR THEIR PREPARATION | Solubest Ltd. (IL) | 2010-06-30 | — | — | EP | claimed |
| WO-2009040818-A9 | COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE COMPOUNDS AND METHOD FOR THEIR PREPARATION | SOLUBEST LTD (IL) | 2010-05-20 | — | — | WO | claimed |
| US-20090098200-A1 | COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE COMPOUNDS AND METHOD FOR THEIR PREPARATION | SOLUBEST LTD. (IL) | 2009-04-16 | — | — | US | claimed |
| WO-2009040818-A1 | COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE COMPOUNDS AND METHOD FOR THEIR PREPARATION | SOLUBEST LTD (IL) | 2009-04-02 | — | — | WO | claimed |
| US-20230398132-A1 | PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME | GREENWOOD BRANDS, LLC (US) | 2023-12-14 | — | — | US | disclosed |
| US-6294192-B1 | PHARMACEUTICAL COMPOSITIONS CAPABLE OF SOLUBILIZING THERAPEUTICALLY EFFECTIVE AMOUNTS OF HYDROPHOBIC THERAPEUTIC AGENTS. CARRIER INCLUDES A HYDROPHILIC SURFACTANT AND A HYDROPHOBIC SURFACTANT, AQUEOUS DISPERSION | LIPOCINE, INC. | 2001-09-25 | — | — | US | disclosed |
| EP-0878549-A2 | Process for the enzymatic production of fructosylated compounds | Chemisches Laboratorium Dr. Kurt Richter GmbH (DE) | 1998-11-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170260117-A1 | Method of Making Vitamin K1 | PROC, VKORC1L1, VKORC1 | PTGS1 684/4885PDE4A 4319/4885SNCA 2490/4885 |
| US-20190000862-A1 | METHODS AND SYSTEMS FOR THE DELIVERY OF A THERAPEUTIC AGENT | TMEM205, NUP205, PIGS | PTGS1 555/4885PDE4A 1466/4885SNCA 3055/4885 |
| US-10144692-B2 | Method of making vitamin K1 | PROC, VKORC1L1, VKORC1 | PTGS1 684/4885PDE4A 4319/4885SNCA 2490/4885 |
| US-20230398132-A1 | PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME | ABCB11, SLC47A1, SLC46A1 | PTGS1 1193/4885PDE4A 395/4885SNCA 4664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.